Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on Current Treatment approach to a mild to moderate atopic dermatitis patient.
For patients with mild to moderate atopic dermatitis, the primary treatment approach focuses on moisturizing the skin. Regular use of emollients helps to restore the skin barrier, reducing dryness and irritation. Patients are encouraged to apply these moisturizers multiple times a day, especially after bathing.
Topical corticosteroids are commonly prescribed to manage inflammation and itching. These medications come in various strengths, allowing healthcare providers to tailor treatment based on the severity of the symptoms. Patients should apply the corticosteroids as directed, typically once or twice daily, for the best results.
In addition to corticosteroids, calcineurin inhibitors like tacrolimus or pimecrolimus can be used as an alternative treatment. These medications help reduce inflammation without the side effects associated with long-term steroid use. They are particularly useful for sensitive areas, such as the face and neck.
Therefore, get an overall knowledge of the current Treatment approach to a mild to moderate atopic dermatitis patient. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Beyond What Is Visible in Myelofibrosis?
2.
FDA approves rivanetin as the first-line treatment for lung cancer.
3.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
4.
New First-Line Option for Advanced ALK-Positive Lung Cancer
5.
Certain surgical gestures during prostate removal linked to better sexual function recovery
1.
Tremelimumab: A Potential Breakthrough in Cancer Treatment
2.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
3.
Artificial Intelligence for Early Cancer Detection Leveraging Multi-Omics: A Comprehensive Review
4.
Harnessing Snake Venom in Hematology: From Toxins to Life-Saving Therapeutics
5.
Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation